XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net Income $ 3,119,126 $ 2,591,936
Adjustments to reconcile net income to net cash provided by operating activities -    
Amortization of deferred financing costs 75,073 95,378
Depreciation 3,287 3,398
Non cash compensation expense 9,798 9,798
Loss on write-down of investment in privately held company 20,000
Changes in operating assets and liabilities:    
Interest receivable on loans (107,088) (161,823)
Other assets (48,052) (15,922)
Accounts payable and accrued expenses (15,166) 24,730
Deferred origination fees 199,381 75,332
Net cash provided by operating activities 3,236,359 2,642,827
Cash flows from investing activities:    
Issuance of short term loans (42,417,500) (30,314,500)
Collections received from loans 29,030,264 20,649,870
Purchase of fixed assets (1,666)
Net cash used in investing activities (13,387,236) (9,666,296)
Cash flows from financing activities:    
Proceeds from line of credit, net 4,802,752 9,691,647
Proceeds from public offering, net 9,882,780
Proceeds from exercise of stock options and warrants 48,735 20,440
Dividends paid (2,839,193) (2,457,455)
Cash restricted for reduction of line of credit (1,719,542)
Deferred financing costs (20,380) (43,122)
Purchase of treasury shares (172,156)
Net cash provided by financing activities 10,155,152 7,039,354
Net increase in cash 4,275 15,885
Cash, beginning of period 136,441 96,299
Cash, end of period 140,716 112,184
Supplemental Cash Flow Information:    
Taxes paid during the period 642 2,971
Interest paid during the period $ 1,142,341 $ 713,428